Эдуард Авербух

Отделение: Офтальмология
Должность: Офтальмолог
Языки: Русский, Иврит
Принимает: только взрослых

Доктор Эдуард Авербух. Руководитель центра офтальмологии в "Хадасса Хар ха-Цофим".

Образование

Родился в Ленинграде, иммигрировал в Израиль в 1976 г. В 1986 получил диплом врача в медицинской школе "Хадасса" при Еврейском университете (Иерусалим)

Специализация

Заболевания сетчатки глаза.

Профессиональная деятельность

  • 1997-1998: консультирующий врач-офтальмолог в офтальмологическом отделении "Хадассы" на горе Скопус
  • 1998-1999: получил специализацию в области заболеваний и хирургии сетчатки и стекловидного тела в университете Торонто (Канада)
  • 1999-по н. вр.: консультирующий врач-офтальмолог в подразделении патологий сетчатки отделения офтальмологии "Хадассы"
  • 2002-по н. вр.: старший врач отделения офтальмологии "Хадассы".

Член Израильской Медицинской Ассоциации, Израильского офтальмологического общества, Американской Академии Офтальмологии, Европейского общества специалистов по лечению патологий сетчатки.

Научные публикации

The novel triangular suture technique for intraocular Lens fixation in patients with pseudoexfoliation syndrome suffering from dislocation: Case series
Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection
Advanced Optical Analysis of Divergence Between the Foci of the Neodymium-Doped Yttrium Aluminum Garnet (Nd:YAG) and Aiming Beam Lasers
Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study
Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment
Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia
Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients
Naturally-occurring myopia and loss of cone function in a sheep model of achromatopsia
Correlation of Response between Both Eyes to First- and Second-Line Anti-VEGF Therapy in Diabetic Macular Edema
Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep
Socioeconomic status and visual outcome in patients with neovascular age-related macular degeneration
PERSISTENT LOCULATED SUBRETINAL FLUID AFTER RHEGMATOGENOUS RETINAL DETACHMENT SURGERY
Consecutive unilateral recording of the two eyes affects dark-adapted ERG responses, when compared to simultaneous bilateral recording
Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of CNGA3 Achromatopsia
Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep
Gene Augmentation Therapy for a Missense Substitution in the cGMP-Binding Domain of Ovine CNGA3 Gene Restores Vision in Day-Blind Sheep
Evaluation of the association of single nucleotide polymorphisms in the PRPH2 gene with adult-onset foveomacular vitelliform dystrophy
Characterising the phenotype and progression of sporadic adult-onset foveomacular vitelliform dystrophy
Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcome
Flicker cone function in normal and day blind sheep: a large animal model for human achromatopsia caused by CNGA3 mutation
Bevacizumab treatment for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy
Association of pattern dystrophy with an HTRA1 single-nucleotide polymorphism
Bevacizumab for choroidal neovascularization related to inflammatory diseases
Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy
A novel day blindness in sheep: epidemiological, behavioural, electrophysiological and histopathological studies
Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel
A novel de novo PAX6 mutation in an Ashkenazi-Jewish family with aniridia
Application of the standard photodynamic treatment protocol for symptomatic circumscribed choroidal hemangioma
Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms
Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids
The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation
Traumatic pediatric retinal detachment: a comparison between open and closed globe injuries
Bilateral iridociliary T-cell lymphoma
Показать ещё 27 статей Скрыть статьи
Заболевания
Ахроматопсия
Процедуры
Генная терапия
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы